Antagonist effect on antigen

Industry

CPC
C07K2317/76

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K2317/00Immunoglobulins specific feautures

Current Industry

C07K2317/76Antagonist effect on antigen

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Bispecific molecules comprising an HIV-1 envelope targeting arm
- Patent number 12,173,051
- Issue date Dec 24, 2024
- Duke University
- Barton F. Haynes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and t...
- Patent number 12,173,064
- Issue date Dec 24, 2024
- Janssen Biotech, Inc.
- Raluca Verona
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
C-KIT antibodies and method for treating cancer with such
- Patent number 12,173,067
- Issue date Dec 24, 2024
- Granular Therapeutics Limited
- William James Jonathan Finlay
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions comprising B7H3 chimeric antigen receptors
- Patent number 12,173,071
- Issue date Dec 24, 2024
- Seattle Children's Hospital
- Adam Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treatment by targeting VCAM1 and MAEA
- Patent number 12,173,073
- Issue date Dec 24, 2024
- Albert Einstein College of Medicine
- Paul S. Frenette
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific polypeptides against CD137
- Patent number 12,173,082
- Issue date Dec 24, 2024
- Alligator Bioscience AB
- Eva Dahlén
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 12,171,819
- Issue date Dec 24, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-sema3a antibodies and uses thereof
- Patent number 12,173,068
- Issue date Dec 24, 2024
- Bayer Aktiengesellschaft
- Dorian Schönfeld
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RSV-specific antibodies and functional parts thereof
- Patent number 12,173,050
- Issue date Dec 24, 2024
- MedImmune Limited
- Nancy Ulbrandt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that bind CD3 epsilon
- Patent number 12,173,282
- Issue date Dec 24, 2024
- Twist Bioscience, Inc.
- Aaron Sato
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-IL-31RA antibody-containing formulations
- Patent number 12,171,830
- Issue date Dec 24, 2024
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Daisuke Kameoka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combinational uses of nitroxoline and its analogues with chemothera...
- Patent number 12,171,754
- Issue date Dec 24, 2024
- Jiangsu Yahong Meditech Co., Ltd.
- Ke Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-coronavirus antibodies and methods of use
- Patent number 12,172,038
- Issue date Dec 24, 2024
- AbCellera Biologics Inc.
- Kathryn Westendorf
- G01 - MEASURING TESTING
Information Patent Grant
N-terminal epitopes in amyloid beta and conformationally-selective...
- Patent number 12,173,055
- Issue date Dec 24, 2024
- The University of British Columbia
- Neil R. Cashman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion proteins comprising extracellular domain of human CD22
- Patent number 12,173,065
- Issue date Dec 24, 2024
- SINOMAB BIOSCIENCE LIMITED
- Shui-On Leung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HIV-1 gp120 CD4 binding site antibodies targeting HIV escape mutants
- Patent number 12,173,052
- Issue date Dec 24, 2024
- The Rockefeller University
- Ron Diskin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Splicing modulator antibody-drug conjugates and methods of use
- Patent number 12,172,986
- Issue date Dec 24, 2024
- Eisai R&D Management Co., Ltd.
- Ermira Pazolli
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions for inhibiting fibrin-VLDL receptor-dependent inflamma...
- Patent number 12,171,802
- Issue date Dec 24, 2024
- University of Maryland, Baltimore
- Leonid V. Medved
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Abituzumab for the treatment of colorectal cancer
- Patent number 12,171,829
- Issue date Dec 24, 2024
- Merck Patent GmbH
- Giorgio Massimini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
LTBP complex-specific inhibitors of TGFβ and uses thereof
- Patent number 12,173,059
- Issue date Dec 24, 2024
- SCHOLAR ROCK, INC.
- Thomas Schurpf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized and affinity-matured anti-CEACAM1 antibodies
- Patent number 12,173,066
- Issue date Dec 24, 2024
- The Brigham & Women's Hospital, Inc.
- Richard S. Blumberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PD-L1/anti-LAG3 bispecific antibodies and uses thereof
- Patent number 12,173,070
- Issue date Dec 24, 2024
- ABL Bio Inc.
- Eunyoung Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 12,168,043
- Issue date Dec 17, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of treating cancer using a combination of entinostat and an...
- Patent number 12,168,054
- Issue date Dec 17, 2024
- SYNDAX PHARMACEUTICALS, INC.
- Peter Ordentlich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-EGFR/anti-4-1BB bispecific antibody
- Patent number 12,168,690
- Issue date Dec 17, 2024
- ABL Bio Inc.
- Yeryoung Yong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies to mucin-16 (MUC16), encoding polynucleotides and method...
- Patent number 12,168,696
- Issue date Dec 17, 2024
- Memorial Sloan Kettering Cancer Center
- David Spriggs
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tissue factor pathway inhibitor antibodies and uses thereof
- Patent number 12,168,698
- Issue date Dec 17, 2024
- Pfizer Inc.
- Debra Pittman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-myostatin antibodies, polypeptides containing variant fc regio...
- Patent number 12,169,205
- Issue date Dec 17, 2024
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Yoshinao Ruike
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Vaccine in combination with an immune checkpoint inhibitor for use...
- Patent number 12,168,045
- Issue date Dec 17, 2024
- Ultimovacs ASA
- Gustav Gaudernack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies and variants thereof against PD-L1
- Patent number 12,168,688
- Issue date Dec 17, 2024
- Nanjing Legend Biotech Co., Ltd.
- Shuai Yang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTI-IL-11RA ANTIBODIES
- Publication number 20240425606
- Publication date Dec 26, 2024
- Lassen Therapeutics 1, Inc.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEIN S ANTIBODIES, METHODS OF MAKING AND USES THEREOF
- Publication number 20240425613
- Publication date Dec 26, 2024
- Vega Therapeutics, Inc.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PDGF-B ANTIBODIES AND PHARMACEUTICAL COMPOSITION THEREOF
- Publication number 20240425574
- Publication date Dec 26, 2024
- Regeneron Pharmaceuticals, Inc.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PAN-ELR+ CXC CHEMOKINE ANTIBODIES FOR THE TREATMENT OF HIDRADENITIS...
- Publication number 20240425577
- Publication date Dec 26, 2024
- Eli Lilly and Company
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PD-1 BINDING DOMAINS
- Publication number 20240425594
- Publication date Dec 26, 2024
- Merus N.V.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TrkA ANTIBODY AND APPLICATION THEREOF
- Publication number 20240425605
- Publication date Dec 26, 2024
- 4B TECHNOLOGIES (SUZHOU) LIMITED
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-ADAMTS13 ANTIBODY AND USE THEREOF
- Publication number 20240425614
- Publication date Dec 26, 2024
- Nara Medical University
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLYCOPROTEIN A REPETITIONS PREDOMINANT (GARP)-BINDING ANTIBODIES AN...
- Publication number 20240425571
- Publication date Dec 26, 2024
- Ohio State Innovation Foundation
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS THAT INHIBIT IL-23 SIGNALING
- Publication number 20240425579
- Publication date Dec 26, 2024
- Y-TRAP, INC.
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-VEGFR1 ANTIBODIES AND THEIR USES
- Publication number 20240425603
- Publication date Dec 26, 2024
- JANSSEN BIOTECH, INC.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEW INTERLEUKIN-7 IMMUNOCONJUGATES
- Publication number 20240425561
- Publication date Dec 26, 2024
- HOFFMANN-LA ROCHE INC.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods for Inhibiting Fibrosis in a Subject in Need Thereof
- Publication number 20240424091
- Publication date Dec 26, 2024
- University of Leicester
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST ANTIBODY
- Publication number 20240424092
- Publication date Dec 26, 2024
- Genentech, Inc.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PD-1 BINDING DOMAINS
- Publication number 20240425595
- Publication date Dec 26, 2024
- Merus N.V.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-ANG2 ANTIBODY, PREPARATION METHOD THEREFOR, AND APPLICATION TH...
- Publication number 20240425575
- Publication date Dec 26, 2024
- SOTER BIOPHARMA PTE. LTD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-IL-33 Antibodies and Uses Thereof
- Publication number 20240425580
- Publication date Dec 26, 2024
- Regeneron Pharmaceuticals, Inc.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY MOLECULES TO DENGUE VIRUS AND USES THEREOF
- Publication number 20240425569
- Publication date Dec 26, 2024
- VISTERRA, INC.
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
CHIMERIC SECRETORY COMPONENT POLYPEPTIDES AND USES THEREOF
- Publication number 20240425570
- Publication date Dec 26, 2024
- THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PD-1 ANTIBODY AND USE THEREOF
- Publication number 20240425593
- Publication date Dec 26, 2024
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RECEPTOR-MEDIATED DELIVERY OF NUCLEIC ACIDS
- Publication number 20240425598
- Publication date Dec 26, 2024
- Kodikaz Therapeutic Solutions, Inc.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
- Publication number 20240425602
- Publication date Dec 26, 2024
- Novartis AG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY CONJUGATES FOR THE TREATMENT OF CANCER
- Publication number 20240417477
- Publication date Dec 19, 2024
- B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
- Moshe ELKABETS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYPEPTIDES, CELLS, AND METHODS INVOLVING ENGINEERED CD16
- Publication number 20240417441
- Publication date Dec 19, 2024
- Regents of the University of Minnesota
- Bruce Kenneth Walcheck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SINGLE DOMAIN ANTIBODIES TARGETING THE S2 SUBUNIT OF SARS-COV-2 SPI...
- Publication number 20240417446
- Publication date Dec 19, 2024
- The USA, as represented by the Secretary, Department of Health and Human Serv...
- Mitchell Ho
- G01 - MEASURING TESTING
Information Patent Application
BISPECIFIC IMMUNE CELL ENGAGERS TARGETING HIV AND METHODS OF USE TH...
- Publication number 20240417448
- Publication date Dec 19, 2024
- The Wistar Institute of Anatomy and Biology
- David Weiner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
- Publication number 20240417471
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- John P. COGSWELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LAG-3 ANTAGONIST THERAPY FOR HEMATOLOGICAL CANCER
- Publication number 20240417473
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- Shivani SRIVASTAVA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIOPHARMACEUTICAL COMPOSITIONS AND RELATED METHODS
- Publication number 20240417456
- Publication date Dec 19, 2024
- GlaxoSmithKline Intellectual Property Development Limited
- Steven GRANT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED...
- Publication number 20240417461
- Publication date Dec 19, 2024
- Genentech, Inc.
- Hilary CLARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODY TARGETING TIGIT
- Publication number 20240417462
- Publication date Dec 19, 2024
- Shanghai Celgen Bio-Pharmaceutical Co., Ltd.
- Yi CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Antagonist effect on antigen

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Bispecific molecules comprising an HIV-1 envelope targeting arm

Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and t...

C-KIT antibodies and method for treating cancer with such

Methods and compositions comprising B7H3 chimeric antigen receptors

Methods of treatment by targeting VCAM1 and MAEA

Bispecific polypeptides against CD137

Peptides and combination of peptides for use in immunotherapy again...

Anti-sema3a antibodies and uses thereof

RSV-specific antibodies and functional parts thereof

Antibodies that bind CD3 epsilon

Anti-IL-31RA antibody-containing formulations

Combinational uses of nitroxoline and its analogues with chemothera...

Anti-coronavirus antibodies and methods of use

N-terminal epitopes in amyloid beta and conformationally-selective...

Fusion proteins comprising extracellular domain of human CD22

HIV-1 gp120 CD4 binding site antibodies targeting HIV escape mutants

Splicing modulator antibody-drug conjugates and methods of use

Compositions for inhibiting fibrin-VLDL receptor-dependent inflamma...

Abituzumab for the treatment of colorectal cancer

LTBP complex-specific inhibitors of TGFβ and uses thereof

Humanized and affinity-matured anti-CEACAM1 antibodies

Anti-PD-L1/anti-LAG3 bispecific antibodies and uses thereof

Peptides and combination of peptides for use in immunotherapy again...

Method of treating cancer using a combination of entinostat and an...

Anti-EGFR/anti-4-1BB bispecific antibody

Antibodies to mucin-16 (MUC16), encoding polynucleotides and method...

Tissue factor pathway inhibitor antibodies and uses thereof

Anti-myostatin antibodies, polypeptides containing variant fc regio...

Vaccine in combination with an immune checkpoint inhibitor for use...

Antibodies and variants thereof against PD-L1

Patents Applicationslast 30 patents

ANTI-IL-11RA ANTIBODIES

PROTEIN S ANTIBODIES, METHODS OF MAKING AND USES THEREOF

ANTI-PDGF-B ANTIBODIES AND PHARMACEUTICAL COMPOSITION THEREOF

PAN-ELR+ CXC CHEMOKINE ANTIBODIES FOR THE TREATMENT OF HIDRADENITIS...

NOVEL PD-1 BINDING DOMAINS

TrkA ANTIBODY AND APPLICATION THEREOF

ANTI-ADAMTS13 ANTIBODY AND USE THEREOF

GLYCOPROTEIN A REPETITIONS PREDOMINANT (GARP)-BINDING ANTIBODIES AN...

COMPOSITIONS AND METHODS THAT INHIBIT IL-23 SIGNALING

ANTI-VEGFR1 ANTIBODIES AND THEIR USES

NEW INTERLEUKIN-7 IMMUNOCONJUGATES

Methods for Inhibiting Fibrosis in a Subject in Need Thereof

METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST ANTIBODY

NOVEL PD-1 BINDING DOMAINS

ANTI-ANG2 ANTIBODY, PREPARATION METHOD THEREFOR, AND APPLICATION TH...

Anti-IL-33 Antibodies and Uses Thereof

ANTIBODY MOLECULES TO DENGUE VIRUS AND USES THEREOF

CHIMERIC SECRETORY COMPONENT POLYPEPTIDES AND USES THEREOF

ANTI-PD-1 ANTIBODY AND USE THEREOF

RECEPTOR-MEDIATED DELIVERY OF NUCLEIC ACIDS

COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH

ANTIBODY CONJUGATES FOR THE TREATMENT OF CANCER

POLYPEPTIDES, CELLS, AND METHODS INVOLVING ENGINEERED CD16

SINGLE DOMAIN ANTIBODIES TARGETING THE S2 SUBUNIT OF SARS-COV-2 SPI...

BISPECIFIC IMMUNE CELL ENGAGERS TARGETING HIV AND METHODS OF USE TH...

CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

LAG-3 ANTAGONIST THERAPY FOR HEMATOLOGICAL CANCER

BIOPHARMACEUTICAL COMPOSITIONS AND RELATED METHODS

NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED...

MONOCLONAL ANTIBODY TARGETING TIGIT